Antiglucocorticoid treatments in psychiatry

Psychoneuroendocrinology

Volumn 22, Issue SUPPL. 1, 1997, Pages

  Reus, Victor I ^a,b   Wolkowitz, Owen M ^a   Frederick, Sydney ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Box F 0984 ^*  (United States)

Author keywords

Cortisol; Cushing's syndrome; Dehydroepiandrosterone; Depression; Ketoconazole; Memory

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID ANTAGONIST; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE; PRASTERONE;

ARTICLE; COGNITION; CORTICOSTEROID METABOLISM; CUSHING SYNDROME; DEPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; LIBIDO; MOOD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; SLEEP PARAMETERS; SYMPTOMATOLOGY;

DEHYDROEPIANDROSTERONE; HORMONE ANTAGONISTS; HUMANS; KETOCONAZOLE; MENTAL DISORDERS;

EID: 0030874735     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(97)00016-4     Document Type: Article

References (25)

1. Amsterdam, J, Mosley and PD, Rosenzweig, M (1994) Assessment of adrenocortical activity in refractory depression: Steroid suppression with ketoconazole. In: Nolan, W, Zohar, J, Roose, S and Amsterdam, J (Eds) Refractory Depression, John Wiley and Sons, New York, pp. 199-210.
2. Anand, A, Malison, R, McDougle, CJ and Price, LH (1995) Antiglucocorticoid treatment of refractory depression with ketoconazole: A case report. Biol Psychiatry 37, 338-340.
3. Barden, N, Reul, J and Holsboer, F (1995) Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 18, 6-11.
4. Fahlke, C, Hard, E, Thomasson, R, Engel, J and Hansen, S (1994) Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharmacol Biochem Behav 48, 977-981.
5. Heuser, IJE, Schweiger, U, Gotthardt, U, Schmider, J, Lammers, C-H, Dettling, M, Yassouridis, A and Holsboer, F (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153, 93-99.
6. Morales, AJ, Nolan, JJ, Nelson, JC and Yen, SSC (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78, 1360-1367.
7. Murphy, BEP, Dhar, V, Ghadirian, AM, Chouinard, G and Keller, R (1991) Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 11, 121-126.
8. O'Dwyer, AM, Lightman, SL, Marks, MN and Checkley, SA (1995) Treatment of major depression with metyrapone and hydrocortisone. J Affective Dis 33, 123-128.
9. Piazza, PV, Maccari, S, Deminiere, JM, Le Moal, M, Mormede, P and Simon, H (1991) Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 88, 2088-2092.
10. Piazza, PV, Marinelli, M, Jodogne, C, Deroche, V, Rouge-Pont, F, Maccari, S, Le Moal, M and Simon, H (1994) Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 658, 259-260.
11. Quarton, GC, Clark, LD, Cobb, S and Bauer, W (1955) Mental disturbances associated with ACTH and cortisone: A review of explanatory hypotheses. Medicine 34, 13-50.
12. Ravaris, CL, Sateia, MJ, Beroza, KW and Noordsy, DL (1988) Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman. Arch Gen Psychiatry 45, 966-967.
13. Raven, PW, O'Dwyer, AM, Taylor, NF and Checkley, SA (1996) The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles. Psychoneuroendocrinology 21, 277-286.
14. Reus, VI (1982) Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biol Psychiatry 17, 317-325.
15. Reus VI (1984) Diagnosis in endocrinology and psychiatry: From Cushing's syndrome to disorders of mood. In: Zegans, L, Temoshok, L and Van Dyke, C (Eds) Emotions in Health and Illness, Grune and Stratton, New York, pp. 23-34.
16. Reus VI (1987) Behavioral implications of hypothalamic-pituitary-adrenal dysfunction. In: Halbreich, U (Ed) Hormones and Behavior, Raven Press, New York, pp. 385-401.
17. Reus, VI and Wolkowitz, OM (1993) Behavioral side effects of corticosteroid therapy. Psychiatr Ann 23, 703-708.
18. Sovner, R and Fogelman, S (1996) Ketoconazole therapy for atypical depression. J Clin Psychiatry 57, 227-228.
19. Starkman, MN, Schteingart, DE and Schork, MA (1981) Cushing's syndrome: Changes in psychiatric symptomatology and hormone levels with treatment. Psychosom Med 45, 83.
20. Starkman, MN, Schteingart, DE and Schork, MA (1986) Cushing's syndrome after treatment: Changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 19, 177-188.
21. Thakore, JH and Dinan, TG (1995) Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 37, 364-368.
22. Wolkowitz, OM, Rubinow, DR, Doran, AR, Breier, A, Berrettini, WH, Kling, MA and Pickar, D (1990a) Prednisone effects on neurochemistry and behavior. Arch Gen Psychiatry 47, 963-968.
23. Wolkowitz, OM, Reus, VI, Weingartner, H, Thompson, K, Breier, A, Doran, AR, Rubinow, D and Pickar, D (1990b) Cognitive effects of corticosteroids. Am J Psychiatry 147, 1297-1303.
24. Wolkowitz, OM, Reus, VI, Ingbar, J, Brizendine, L and Weingartner, H (1993) Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry 150, 810-812.
25. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H (in press) Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry.